Delay is no longer an option — it’s time to step up the fight to end drug-resistant TB. A new report published by The Economist Intelligence Unit (EIU), and with support from Johnson & Johnson, emphasizes the urgent need for focused global action to address the growing threat of DR-T
![Paul Thorn, DR-TB survivor, speaking on camera during segment on efforts to combat the threat of drug-resistant tuberculosis](https://jnj-content-lab2.brightspotcdn.com/dims4/default/def1a40/2147483647/strip/true/crop/3174x1785+0+30/resize/1440x810!/quality/90/?url=https%3A%2F%2Fjnj-production-jnj.s3.us-east-1.amazonaws.com%2Fbrightspot%2F3f%2F87%2Ff8b877e8b1f3cbfc1356c0dc0ea5%2Fscreen-shot-2019-05-09-at-3-00-24-pm.png)